Leukocyte Integrin Antagonists as a Novel Option to Treat Dry Age-Related Macular Degeneration

Monica Baiula(University of Bologna), Santi Spampinato(University of Bologna)
Frontiers in Pharmacology
January 29, 2021
10.3389/fphar.2020.617836
Cited by 8

Related Papers

Functional Selectivity and Antinociceptive Effects of a Novel KOPr Agonist
|Frontiers in Pharmacology|2020|51
Selective detection of α4β1 integrin (VLA‐4)‐expressing cells using peptide‐functionalized nanostructured materials mimicking endothelial surfaces adjacent to inflammatory sites
|Peptide Science|2017|19